Abiso, Alberto A.
HRN: 22-20-74 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/18/2022
CEFTAZIDIME 1GM (VIAL)
12/18/2022
12/24/2022
IVT
2g
Q8
T/C PTB Relapse Vs CAP MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes